Top CMOs in China
Pharma Tech Outlook
Shaping The Next Chapter of Manufacturing
line

Top 5 CMOs in China - 2023

line

In 2023, Contract Manufacturing Organizations (CMOs) in the APAC region have undergone substantial transformations driven by pivotal trends. These include rapid technological advancements, such as automation, robotics, and data analytics, which have enhanced efficiency and unlocked new capabilities for CMOs. Disruptions in the supply chain have also left a profound impact on CMOs. Factors like natural disasters, political instability, and trade disputes have disrupted the flow of raw materials, components, and finished products, disrupting production schedules and delivery timelines.

In addition, it is worth noting that significant shifts have taken place in the regulatory framework governing CMOs in the APAC region. Governments have recognized the importance of ensuring quality standards, protecting intellectual property, preserving the environment, and safeguarding data privacy. As a result, they have introduced new regulations or revised existing ones, addressing these concerns comprehensively. These regulatory developments have garnered attention within the region and propelled CMOs in the APAC region to rank among the top echelons worldwide. This recognition is a testament to the region’s commitment to upholding high standards and fostering an environment conducive to contract manufacturing excellence.

This edition of Pharma Tech Outlook features top CMOs across APAC that have emerged as industry’s frontrunners despite the market challenges and roadblocks. It delves deeper into showcasing the best-performing CMOs in China.

It also includes the valuable perspectives of Chow Woai Sheng, Vice President of Global Instrument Manufacturing and Singapore General Manager, Agilent Technologies; Max Brescia, Senior Global Director, AbbVie Contract Manufacturing; and Haichen Yang, Vice President, Clinical Research, Amicus Therapeutics Inc. They share their views on the present predicament, the challenges, the latest trends, and the prospects of CMOs across APAC. We hope these valuable insights from industry leaders featured in this edition will assist you in making informed decisions for your businesses.

    Top CMOs in China

    MabPlex is a CMO powerhouse with over one million liters of annual output. We specialize in addressing the unmet needs of our clients. MabPlex improves lives through innovation and is poised to remain a key player in the pharmaceutical industry. ... read full profile
    Through its commitment to customized CDMO services as well as high quality pharmaceutical products, Xi’an Manareco sets a new standard for excellence. The company can act as a one-stop outsourcing partner for pharmaceutical intermediates and APIs, from investigational to large-scale commercial development. Xi'an Manareco boosts project at every stage. ... read full profile
    Aosikang Biological (Nantong)
    Aosikang Biological (Nantong) is a leading biopharmaceutical company in the field of Chemistry, Manufacturing, and Controls, specializing in versatile production processes and collaborating with prestigious institutions for innovation.
    Aton Biotech
    Aton Biotech is a rapidly growing Contract Development and Manufacturing Organization (CDMO) offering comprehensive services for the biopharmaceutical industry, including cell line development and clinical trials for various biological drugs.
    Beijing BioInno Biotechnology
    Beijing BioInno Biotechnology is a global biopharmaceutical CDMO specializing in serum-free cell culture media development and manufacturing, offering services like cell line development, process development, clinical material manufacturing, IND application filing, and GMP manufacturing.